The Hair Loss Encyclopedia

Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Comparison of Effectiveness of Weekly Azathioprine Pulse and Betamethasone Oral Mini Pulse in the Treatment of Moderate to Severe Alopecia Areata

research Comparison of effectiveness of weekly azathioprine pulse (WAP) and betamethasone oral mini pulse (BOMP) in the treatment of moderate to severe alopecia areata

May 2015 in “Journal of The American Academy of Dermatology”

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Clinical Evaluation of Intradermal Platelet-Rich Plasma Administration Along with Oral Biotin Supplement for the Management of Androgenetic Alopecia in Adult Males: A Randomized Clinical Trial

research Clinical Evaluation of Intradermal Platelet Rich Plasma Administration along with Oral Biotin Supplement for the Management of Androgenetic Alopecia in Adult Males: A Randomised Clinical Tria

January 2022 in “Journal of Clinical and Diagnostic Research”

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

research A Review of the Efficacy and Safety Profile of Oral Spironolactone Use for Androgenic Alopecia -Supplemental Text

October 2021

research Faculty Opinions recommendation of Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.

July 2021 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Mechanisms of action and medical evidences of the therapeutic effect of oral gelatin on telogen effluvium and androgenetic alopecia in both men and women

January 2012 in “Surgery”

research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

63 citations , July 2024 in “Journal of the American Academy of Dermatology”

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

research A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.

12 citations , May 2010 in “Journal of Clinical Oncology”

MK-5108 is safe and shows potential against tumors, especially alone.

research Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis

7 citations , September 2024 in “The Journal of Dermatology”

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

research Saline extract of Portulaca elatior leaves with photoprotective and antioxidant activities does not show acute oral and dermal toxicity in mice

6 citations , December 2022 in “Toxicological Research”

research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial

2 citations , November 2025 in “Journal of the American Academy of Dermatology”

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

← Previous page